| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.745 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
HTR4 |
HTR4: 5-hydroxytryptamine receptor 4 |
0.745 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.745 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
POU5F1 |
POU5F1, OCT3, OCT4, OTF3: POU domain, class 5, transcription factor 1 |
0.745 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
HOXC12 |
HOXC12, HOC3F, HOX3F: Homeobox protein Hox-C12 |
0.745 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
JAG2 |
JAG2: Jagged-2 precursor |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
OR51B4 |
OR51B4: Olfactory receptor 51B4 |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
GPR92 |
GPR92, GPR93: Probable G-protein coupled receptor 92 |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
NMUR2 |
NMUR2, NMU2R, TGR1: Neuromedin-U receptor 2 |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
GPR21 |
GPR21: Probable G-protein coupled receptor 21 |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
GPR82 |
GPR82: Probable G-protein coupled receptor 82 |
0.745 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
0.745 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
P2RY12 |
P2RY12, HORK3: P2Y purinoceptor 12 |
0.745 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
PKP2 |
PKP2: Plakophilin-2 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
ADRA2A |
IPI00031712 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
FAM62A |
FAM62A, KIAA0747, MBC2: Protein FAM62A |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
OR1G1 |
OR1G1, OR1G2: Olfactory receptor 1G1 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
RXFP1 |
IPI00719123 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
P2RY12 |
P2RY12, HORK3: P2Y purinoceptor 12 |
0.745 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.745 |
Evidence |
|